Your account is not claimed yet. You can sign up with ORCID to claim your account.

Amarnath Natarajan

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 18

Top Venues

bioRxiv : the preprint server for biology

Nature communications

Cancers

RSC chemical biology

University of Nebraska Medical Center

University of Vermont (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Nebraska Medical Center

United States

Professor :: Eppley Institute for Cancer Research

Education History

University of Vermont

United States

PHD :: Chemistry

Publications

Rasangi Pathirage, Lorenza Favrot, Cecile Petit, Melvin Yamsek, Sarbjit Singh, Jayapal Reddy Mallareddy, Sandeep Rana, Amarnath Natarajan, Donald R Ronning
Mycobacterium tuberculosis CitA activity is modulated by cysteine oxidation and pyruvate binding. RSC medicinal chemistry 14 (5) (2023)
Savanna Wallin, Yongseok Choi, Gloria E O Borgstahl, Amarnath Natarajan
Design, synthesis, and evaluation of a mitoxantrone probe (MXP) for biological studies. bioRxiv : the preprint server for biology (2023)
Savanna Wallin, Yongseok Choi, Gloria E O Borgstahl, Amarnath Natarajan
Design, synthesis, and evaluation of a mitoxantrone probe (MXP) for biological studies. bioRxiv : the preprint server for biology (2023)
Savanna Wallin, Yongseok Choi, Gloria E O Borgstahl, Amarnath Natarajan
Design, synthesis, and evaluation of a mitoxantrone probe (MXP) for biological studies. bioRxiv : the preprint server for biology (2023)
Rebecca Harris, Ming Yang, Christina Schmidt, Chloe Royet, Yongseok Choi, Amarnath Natarajan, May C Morris, Christian Frezza, Heike Laman
Fbxo7 promotes Cdk6 activity to inhibit PFKP and glycolysis in T cells. The Journal of cell biology 221 (7) (2022)
John Victor Napoleon, Satish Sagar, Sydney P Kubica, Lidia Boghean, Smit Kour, Hannah M King, Yogesh A Sonawane, Ayrianne J Crawford, Nagsen Gautam, Smitha Kizhake, Pawel A Bialk, Eric Kmiec, Jayapal Reddy Mallareddy, Prathamesh P Patil, Sandeep Rana, Sarbjit Singh, Janani Prahlad, Paul M Grandgenett, Gloria E O Borgstahl, Gargi Ghosal, Yazen Alnouti, Michael A Hollingsworth, Prakash Radhakrishnan, Amarnath Natarajan
Small-molecule IKKβ activation modulator (IKAM) targets MAP3K1 and inhibits pancreatic tumor growth. Proceedings of the National Academy of Sciences of the United States of America 119 (18) (2022)
Sandeep Rana, Jayapal Reddy Mallareddy, Sarbjit Singh, Lidia Boghean, Amarnath Natarajan
Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase. Cancers 13 (21) (2021)
Balawant Kumar, Rizwan Ahmad, Swagat Sharma, Saiprasad Gowrikumar, Mark Primeaux, Sandeep Rana, Amarnath Natarajan, David Oupicky, Corey R Hopkins, Punita Dhawan, Amar B Singh
PIK3C3 Inhibition Promotes Sensitivity to Colon Cancer Therapy by Inhibiting Cancer Stem Cells. Cancers 13 (9) (2021)
Smit Kour, Sandeep Rana, Smitha Kizhake, Dragana Lagundžin, David Klinkebiel, Jayapal Reddy Mallareddy, Tom Huxford, Nicholas T Woods, Amarnath Natarajan
Stapling proteins in the RELA complex inhibits TNFα-induced nuclear translocation of RELA. RSC chemical biology 3 (1) (2021)
Jayapal Reddy Mallareddy, Sarbjit Singh, Lidia Boghean, Amarnath Natarajan
Selective CDK9 degradation using a proteolysis-targeting chimera (PROTAC) strategy. Future medicinal chemistry (2021)
Ling Yin, Yongji Zeng, Renya Zeng, Yuanhong Chen, Tian-Li Wang, Kerry J Rodabaugh, Fang Yu, Amarnath Natarajan, Adam R Karpf, Jixin Dong
Protein kinase RNA-activated controls mitotic progression and determines paclitaxel chemosensitivity through B-cell lymphoma 2 in ovarian cancer. Oncogene (2021)
John V Napoleon, Sarbjit Singh, Sandeep Rana, Mourad Bendjennat, Vikas Kumar, Smitha Kizhake, Nicholas Y Palermo, Michel M Ouellette, Tom Huxford, Amarnath Natarajan
Small molecule binding to inhibitor of nuclear factor kappa-B kinase subunit beta in an ATP non-competitive manner. Chemical communications (Cambridge, England) 57 (38) (2021)
Sandeep Rana, Amarnath Natarajan
Small molecule induced polymerization of BCL6 facilitates SIAH1 mediated degradation. Signal transduction and targeted therapy 6 (1) (2021)
Sandeep Rana, Smit Kour, Yogesh A Sonawane, Caroline M Robb, Jacob I Contreras, Smitha Kizhake, Muhammad Zahid, Adam R Karpf, Amarnath Natarajan
Symbiotic prodrugs (SymProDs) dual targeting of NFkappaB and CDK. Chemical biology & drug design 96 (2) (2020)
Alveena Ahmed, Stephen Boulton, Hongzhao Shao, Madoka Akimoto, Amarnath Natarajan, Xiaodong Cheng, Giuseppe Melacini
Recent Advances in EPAC-Targeted Therapies: A Biophysical Perspective. Cells 8 (11) (2019)
Xiao-Feng Zheng, Sanket S Acharya, Katherine N Choe, Kumar Nikhil, Guillaume Adelmant, Shakti Ranjan Satapathy, Samanta Sharma, Keith Viccaro, Sandeep Rana, Amarnath Natarajan, Piotr Sicinski, Jarrod A Marto, Kavita Shah, Dipanjan Chowdhury
A mitotic CDK5-PP4 phospho-signaling cascade primes 53BP1 for DNA repair in G1. Nature communications 10 (1) (2019)
Pawel Nowialis, Katarina Lopusna, Jana Opavska, Staci L Haney, Ajay Abraham, Peike Sheng, Alberto Riva, Amarnath Natarajan, Olga Guryanova, Melanie Simpson, Ryan A Hlady, Mingyi Xie, Rene Opavsky
Catalytically inactive Dnmt3b rescues mouse embryonic development by accessory and repressive functions. Nature communications 10 (1) (2019)
Jacob I Contreras, Caroline M Robb, Hannah M King, Jared Baxter, Ayrianne J Crawford, Smit Kour, Smitha Kizhake, Yogesh A Sonawane, Sandeep Rana, Michael A Hollingsworth, Xu Luo, Amarnath Natarajan
Chemical Genetic Screens Identify Kinase Inhibitor Combinations that Target Anti-Apoptotic Proteins for Cancer Therapy. ACS chemical biology 13 (5) (2018)

Amarnath Natarajan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Amarnath Natarajan